Kiernan Seth
VP, Chief Commercial Officer, Lexicon Pharmaceuticals.
Companies
- Lexicon PharmaceuticalsVP, Chief Commercial Officer Oct 29, 2021 to Mar 1, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Lexicon Pharmaceuticals LXRX53,136 shares2$87.7K at $1.65Feb 28, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 28, 2023Shares withheld for tax 11,813 shares at $2.17 of Lexicon Pharmaceuticals2
- Feb 28, 2023Exercised options 22,963 shares of Lexicon Pharmaceuticals2
- Feb 28, 2023Exercised options 5,286 shares of Lexicon Pharmaceuticals2
- Feb 28, 2023Exercised options 14,833 shares of Lexicon Pharmaceuticals2
- Feb 28, 2022Shares withheld for tax 8,261 shares at $2.85 of Lexicon Pharmaceuticals3
- Feb 28, 2022Exercised options 5,287 shares of Lexicon Pharmaceuticals3
- Feb 28, 2022Exercised options 14,834 shares of Lexicon Pharmaceuticals3
- Feb 28, 2022Exercised options 10,007 shares of Lexicon Pharmaceuticals3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Feb 28, 2022